|
|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
Greenwich LifeSciences Advances Phase 3 Breast Cancer Trial
Greenwich LifeSciences (NASDAQ: GLSI) continues to gain momentum with its Phase III FLAMINGO-01 trial for GLSI-100, a Fast Track designated immunotherapy aimed at preventing breast cancer recurrence. With over 140 sites now enrolling and plans to expand into the UK and Canada, patient-driven interest is accelerating, including waitlists at select locations. Preliminary data from the fully enrolled non-HLA-A*02 arm shows an impressive ~80% reduction in recurrence rate—potentially doubling the market for GLSI-100. A lean operating model and efficient financing strategy are supporting the trial’s growth without near-term dilution, while strategic modifications aim to shorten the path to interim analysis and regulatory approval.
|
|
|
|
Blue Gold Teams with Trust Stamp to Launch Biometric Wallet for Gold-Backed Digital Assets
Blue Gold Limited (NASDAQ: BGL) has signed a strategic LOI with Trust Stamp (NASDAQ: IDAI) to co-develop a biometric, passwordless "Wallet-of-Wallets" for holders of its fully gold-backed Standard Gold Coins (SGCs), each representing one gram of physical gold stored with Brink’s. This next-gen wallet infrastructure will offer institutional-grade, non-custodial security—eliminating passwords and central key storage—while enabling seamless, biometric-controlled access across devices. The move marks a major step in Blue Gold’s mission to build a trusted, transparent digital gold ecosystem.
|
|
|
|
|
Trinity Biotech Secures Order for 9 Million HIV Tests
Trinity Biotech (NASDAQ: TRIB) has landed a major order for 9 million TrinScreen HIV tests, marking a powerful resurgence in global HIV screening and reinforcing its leadership in rapid diagnostics. The order, to be fulfilled over Q4 2025 and Q1 2026, follows WHO approval of Trinity’s outsourced manufacturing model and is expected to significantly boost revenue and profitability. The company also achieved positive Adjusted EBITDA in Q3 2025, up from a $2.1M loss in Q2, as its Comprehensive Transformation Plan delivers results.
|
|
|
|
|
|
|
NioCorp to Begin Construction of Mine Portal at Its Elk Creek Critical Minerals Project
NioCorp (NASDAQ: NB) is set to break ground in Q1 2026 on its $44.6 million Mine Portal Project at the Elk Creek Critical Minerals Project, a vital step toward underground access for niobium, scandium, and titanium production. The twin-ramp portal will support the fully electric Railveyor™ material handling system, reducing upfront capital costs and environmental impact. With Board approval secured, this marks the first major construction phase—advancing NioCorp’s strategic timeline and reinforcing its role in strengthening U.S. supply chains for critical and rare earth minerals.
|
|
|
|
|
XTI Aerospace and Drone Nerds Positioned to Dominate U.S. Drone Market Following FCC Crackdown on Foreign-Made UAS
With the FCC tightening restrictions on foreign-made drones, XTI Aerospace (NASDAQ: XTIA) and its newly acquired subsidiary, Drone Nerds, are poised to become leaders in the domestic commercial drone market. Backed by a full-stack, compliance-ready UAS platform and a national service footprint, Drone Nerds is uniquely positioned to help enterprise and government clients transition to secure, FCC-approved systems. This strategic advantage aligns with evolving national security policies and reinforces XTI’s broader mission to scale compliant, high-performance drone and aviation technologies across critical U.S. industries.
|
|
|
Recent News
|
RedChip TV
|
|
|
|
RedChip Highlights Processa Pharmaceuticals (NASDAQ: PCSA) & Sixty Degrees Pharma (NASDAQ: SXTP)
|
|
|
|
|
|
|
|
|
|
Unlock Smarter Investing with RedChat
|
|
|
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
|
|
Access RedChat now, free of charge.
|
|
|
|
|
Recent Research Coverage Updates
| Company |
Rating |
Price Target |
Firm |
Report Date |
| Gorilla Technology (Nasdaq: GRRR) |
Buy |
$31 |
Cantor Fitzgerald |
December 11, 2025 |
| NioCorp Developments (Nasdaq: NB) |
Outperform |
$12 |
William Blair |
November 20, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$11 |
Noble Capital |
November 14, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
November 13, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$10 |
BTIG |
November 12, 2025 |
| Nova Minerals (Nasdaq: NVA) |
Buy |
$50 |
ThinkEquity |
October 27, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$15 |
Maxim |
October 15, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$8 |
H.C. Wainwright |
September 22, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$11 |
Noble Capital |
October 6, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$4 |
Maxim |
September 22, 2025 |
| XORTX Therapeutics (Nasdaq: XRTX) |
Buy |
$14 |
AGP |
September 18, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$10 |
H.C. Wainwright |
September 12, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
September 11, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
September 10, 2025 |
| Greenwich LifeSciences (Nasdaq: GLSI) |
Buy |
$45 |
Noble |
August 20, 2025 |
| Nexalin Technology (Nasdaq: NXL) |
Buy |
$4 |
Maxim |
August 19, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$7 |
HC Waingwright |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 29, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7.5 |
Northland Securities |
July 23, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$4 |
Titan Partners |
July 17, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$5 |
Maxim |
July 10, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7 |
H.C. Wainwright |
July 9, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 9, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$4 |
HC Wainwright |
July 2, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
July 1, 2025 |
|
|
|
|
|
|
Small Stocks, Big Money™ Podcast
|
|
The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
|
|
Available on:
|
|
|
|
|
|
|
Upcoming Events
|
|
|
Alliance Entertainment Holding Corporation (NASDAQ: AENT)
4:15pm Eastern
Alliance Entertainment is a leading distributor and fulfillment partner at the center of the entertainment and collectibles ecosystem.
|
|
|
|
Jupiter Neurosciences (NASDAQ: JUNS)
4:15pm Eastern
Jupiter Neurosciences, Inc. (Nasdaq: JUNS) is a clinical-stage pharmaceutical company pioneering treatments for neuroinflammation and rare diseases through its proprietary resveratrol delivery platform.
|
|
|
|
Bimergen Energy (OTCQB: BESS)
4:15pm Eastern
Bimergen Energy Corporation is a publicly traded independent power provider and project developer focused on utility-scale battery energy storage systems (BESS) assets.
|
|
|
|
60 Degrees Pharmaceuticals (NASDAQ: SXTP)
04:15pm Eastern
60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases.
|
|
|
|
Archived Events
|
|
|
FatPipe (NASDAQ: FATN)
4:15pm Eastern
FatPipe, Inc. (Nasdaq: FATN) is a pioneer in secure, software-defined networking technologies that simplify and fortify enterprise connectivity.
|
|
|
|
Quote of the Week
|
" One of the funny things about the stock market is that every time one person buys, another sells, and both think they are astute. "
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Need to take risks to gain rewards.
|
|
|
|
|
|
|
